Evidence map

ArticleDiabetes, obesity & metabolism2014

Combined antidiabetic benefits of exenatide and dapagliflozin in diabetic mice.

K Tatarkiewicz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

7 papers cite it

2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
this papercites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 24251534